Are we on the 'right' path in clinical research?
Edye Edens
Relentless research ethicist and regulatory consultant. Attorney by trade, rebel by calling.
On the heels of my video discussing our end of year reflections and new year predictions, and as this is the inaugural newsletter I've committed to writing twice each month, it felt like the time to thread the needle a bit more into the black hole that is my brain..
The longer I spend in this industry, the more I realize just how silo'd we remain based on which part we are in and where our focus lies. It is SO easy to become nuanced into a highly technical space and while brilliant in that particular area, no longer have the bandwidth or ability to also keep up with every other facet and stakeholder. Whilst being a generalist is desirable to most, becoming a specialist is what will move the needle on your career trajectory ~ a never-ending conundrum for many. When you tack on being a contractor at a small firm or an entrepreneur, or really any roles outside of larger organizations capable of dedicated, free available, educational resources, it becomes even easier to over focus and struggle to stay on top of every piece of new information you might need to know.
And, with that sentiment, I often spend an enormous amount of time internally concerned about whether the reading, networking, traveling, and training I attempt to take in is ever enough to equip me to know I am officially on the 'right' path. It is yet one battle to educate oneself enough to remain fluent across every possible industry interaction, and another entirely to ensure that you're doing the best for patients and clinical trials globally while staying ahead on the latest innovations. We would never all agree on exactly what the 'right' path for clinical research in fact is, alas, it isn't the point in sum of the question. Rather, how do we even begin to identify ALL the paths to determine what looks, tastes, smells, feels, and is the 'right' one indeed for our mission is the point. *Cue another one of those feel good sayings about enjoying the journey not just the destination, hehe!
领英推荐
Alas, I remain open and excited to hear all the ways others go about bringing news to their periphery when otherwise buried in billable work, but I have to admit the VOLUME of the info received isn't what concerns me usually. In fact, the concern lies in what to listen to and what to ignore, when these tired eyes still have motivation to wander at the end of a long day, where do I rest them? So, I've done what any of you would do and made a list of what goes into my decision making around what falls into a possible 'right' path for me and what I have to let pass.
All of this with a grain of salt and the knowledge it is ALWAYS easier to write advice than to put it into action. I welcome your comments below on this first newsletter and am open to topics for the next!
Literally The Man Who Wrote the Book(s) on Patient Recruitment
12 个月Congrats on the first newsletter Edye. Looking at your first point, I would say the silos within the industry are one of the things that keeps it from running as effectively as it could. Understandable, with the clinical and/or scientific background that underpins it, but more effective cross-pollination of information and ideas would surely be beneficial.
Clinical Data Manager
1 年Could you please take a moment to review your message?
Computer System Validation & Data Integrity
1 年Ah Edye Edens to riff off your closing, what is the old saying? "Those who can do, those who can't teach, those who can't teach ... blog" ?? (Keep at it!)
Clinical Development Leader | Consultant | Neuroscience Expertise in Parkinson's Disease | Ophthalmology | AI
1 年Very insightful Edye. Enjoyed reading the newsletter. Considering the multifaceted challenges you've mentioned in your newsletter, such as the need to specialize yet maintain a broad perspective, staying updated with the latest innovations, and managing the overwhelming volume of information in the field of clinical research, how do you suggest professionals in this field strike a balance between deepening their expertise in a specific area and maintaining a holistic understanding of the industry? Also, I am curious, how can we effectively filter and prioritize the vast information available to ensure they are not just staying abreast of trends but also contributing to meaningful advancements in clinical trials?